Predicting neurodevelopmental outcomes in neonatal hyperbilirubinemia: a multidimensional nomogram integrating biomarkers and neurobehavioral scores - Report - MDSpire

Predicting neurodevelopmental outcomes in neonatal hyperbilirubinemia: a multidimensional nomogram integrating biomarkers and neurobehavioral scores

  • By

  • Mei Xue

  • Jiansong Yin

  • Jun Lv

  • Jiaping Yu

  • Jing Wang

  • May 29, 2026

  • 0 min

Share

Clinical Report: Forecasting Neurodevelopmental Outcomes in Neonates with Hyperbilirubinemia

Overview

This study evaluates the long-term neurodevelopmental trajectories of neonates with hyperbilirubinemia and develops a predictive model incorporating biomarkers and neurobehavioral assessments. 12.8% of infants exhibited neurodevelopmental impairment at one year.

Background

Neonatal hyperbilirubinemia is a prevalent condition affecting a significant percentage of term and preterm infants, with potential risks for irreversible central nervous system damage. This study addresses the gap in knowledge regarding neurodevelopmental impairment in neonates with hyperbilirubinemia who do not present overt acute symptoms.

Data Highlights

OutcomePercentage
Neurodevelopmental impairment at 12 months12.8% (30/234)

Key Findings

  • 12.8% of neonates with hyperbilirubinemia exhibited neurodevelopmental impairment at 12 months.
  • Elevated C-reactive protein (CRP) is an independent risk factor (OR = 1.097).
  • A higher bilirubin-to-albumin ratio (B/A) is associated with increased risk (OR = 2.587).
  • Increased neuron-specific enolase (NSE) levels correlate with adverse outcomes (OR = 1.285).
  • Higher scores on the Neonatal Behavioral Neurological Assessment (NBNA) serve as a protective factor (OR = 0.749).
  • The predictive model demonstrated an AUC of 0.813.

Clinical Implications

The findings suggest that specific biomarkers can help identify neonates at risk for neurodevelopmental impairment, allowing for targeted follow-up and monitoring. Clinicians should consider these factors when assessing neonates with hyperbilirubinemia.

Conclusion

The study presents a predictive model for assessing neurodevelopmental outcomes in neonates with hyperbilirubinemia.

Related Resources & Content

  1. Frontiers in Pediatrics, 2026 -- A LASSO-Based Nomogram for Predicting Acute Bilirubin Encephalopathy in Newborns with Severe Hyperbilirubinemia
  2. JAMA Network Open, 2023 -- Phototherapy, Morbidity, and Mortality in Very Preterm Newborns
  3. European Radiology, 2023 -- Graph Convolutional Neural Network-Based Prediction of Brain Age Reveals Neurodevelopmental Patterns in Preterm Infants
  4. Frontiers in Pediatrics, 2026 -- Association of the neonatal sequential organ failure assessment score with neurological outcomes in infants diagnosed with hypoxic-ischemic encephalopathy
  5. AAP News, 2023 -- AAP releases updated guidance for managing neonatal hyperbilirubinemia
  6. PMC, 2010 -- Aggressive vs. Conservative Phototherapy for Infants with Extremely Low Birth Weight
  7. Journal of Pediatrics, 2023 -- Unbound Bilirubin and Acute Bilirubin Encephalopathy in Newborns
  8. AAP releases updated guidance for managing neonatal hyperbilirubinemia | AAP News | American Academy of Pediatrics
  9. Aggressive vs. Conservative Phototherapy for Infants with Extremely Low Birth Weight - PMC
  10. Unbound Bilirubin and Acute Bilirubin... : Journal of Pediatrics

Original Source(s)

Related Content